Horizon Therapeutics | search
Click here to view Horizon Therapeutics news from 60+ newspapers.
Bookmark or Share- Amgen acquires Horizon Therapeutics for $27.8bn - Pharmaceutical TechnologyAmgen has acquired Ireland-based biotechnology company Horizon Therapeutics in a $27.8bn (£22.76bn) deal following US Federal Trade Commission (FTC) approval.
- Amgen | A Worldwide Pioneer in BiotechnologyAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
- Amgen completes $28B Horizon buyout that was challenged by FTCAmgen on Friday closed its $27.8 billion acquisition of Horizon Therapeutics, about one month after securing clearance from U.S. antitrust regulators who had challenged the deal. With the acquisition’s completion, Amgen gains access to 12 drugs that had combined sales of $1.8 billion over the first six months of 2023.
- Amgen completes $27.8 billion Horizon Therapeutics dealAmgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain ...
- AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLCTHOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.
More
